XML 17 R17.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Segment Information
6 Months Ended
Jun. 30, 2011
Segment Information [Abstract]  
Segment Information
10. Segment Information
The Company operates as one business segment: the development and commercialization of pharmaceutical products. The Company maintains development operations in the United States and Germany.
Geographic information for the three and six months ended June 30, 2011 and 2010 are as follows:
                                 
    Three months ended     Six months ended  
    June 30,     June 30,  
    2011     2010     2011     2010  
    (in $000s)     (in $000s)  
Revenue
                               
United States
  $ 222     $ 189     $ 459     $ 355  
Germany
    2             3       1  
 
                       
 
  $ 224     $ 189     $ 462     $ 356  
 
                       
Net loss (income)
                               
United States
  $ 4,352     $ 4,012     $ 7,145     $ 7,749  
Germany
    (10 )     877       (337 )     1,648  
 
                       
 
  $ 4,342     $ 4,889     $ 6,808     $ 9,397  
 
                       
 
                               
                 
    June 30,     December 31,  
    2011     2010  
    (in thousands)  
Total Assets
               
United States
  $ 16,651     $ 4,564  
Germany
    196       125  
 
           
 
  $ 16,847     $ 4,689  
 
           
Long Lived Assets, net
               
United States
  $ 153     $ 211  
Germany
    9       11  
 
           
 
  $ 162     $ 222